Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
NPY1R-targeted peptide-mediated delivery of a dual PPAR/ agonist to adipocytes enhances adipogenesis and prevents diabetes progression
Simultaneously, 3-IAA downregulates the antioxidant enzymes GPX3 and GPX7 in tumor cells, enhancing ROS accumulation and inhibiting autophagy, ultimately sensitizing tumors to chemotherapy
Any negative side effects come from the very small risk of bleeding or infection after the shot
This is the most critical area of change for practitioners and patients in 2026
US$ 20.64
US$ 22.12
US$ 29.48
US$ 22.99
US$ 25.63
US$ 25.28
